50
Participants
Start Date
January 1, 2015
Primary Completion Date
November 30, 2026
Study Completion Date
June 28, 2027
Tumor associated antigen lymphocytes (TAA-T)
TAA-T may be generated from donors or recipients and will be tested for specificity to 3 tumor antigens commonly found in hematological malignancies (WT1, PRAME, and SURVIVIN,). The goal of this cell infusion will be to initiate an immune response to residual leukemia or lymphoma that includes multiple antigens and may prevent tumor evasion (through decreased expression of a single antigen).
RECRUITING
Childrens National Medical Center, Washington D.C.
RECRUITING
Tania Jain, MD, Baltimore
Collaborators (1)
Children's National Research Institute
OTHER
Johns Hopkins University
OTHER
Catherine Bollard
OTHER